IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway ; volume:18 ; number:1 ; day:30 ; month:5 ; year:2018 ; pages:1-10 ; date:12.2018
BMC cancer ; 18, Heft 1 (30.5.2018), 1-10, 12.2018
- Urheber
-
Huang, Wei-Chieh
- Beteiligte Personen und Organisationen
-
Tung, Shiao-Lin
Chen, Yao-Li
Chen, Po-Ming
Chu, Pei-Yi
SpringerLink (Online service)
- DOI
-
10.1186/s12885-018-4529-9
- URN
-
urn:nbn:de:101:1-2018080623413824218891
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Huang, Wei-Chieh
- Tung, Shiao-Lin
- Chen, Yao-Li
- Chen, Po-Ming
- Chu, Pei-Yi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Constitutive androstane receptor (CAR) functions as a tumor suppressor via regulating stemness in liver cancer
L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling
TRAF7-targeted HOXA5 acts as a tumor suppressor in prostate cancer progression and stemness via transcriptionally activating SPRY2 and regulating MEK/ERK signaling
Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1
Fascin induces melanoma tumorigenesis and stemness through regulating the Hippo pathway
SRC
SRC
SRC
RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axis
P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs
FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness
Tyrosine kinase SRC-induced YAP1-KLF5 module regulates cancer stemness and metastasis in triple-negative breast cancer
Constitutive androstane receptor (CAR) functions as a tumor suppressor via regulating stemness in liver cancer
L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling
TRAF7-targeted HOXA5 acts as a tumor suppressor in prostate cancer progression and stemness via transcriptionally activating SPRY2 and regulating MEK/ERK signaling
Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1
Fascin induces melanoma tumorigenesis and stemness through regulating the Hippo pathway
SRC
SRC
SRC
RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axis
P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs
FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness
Tyrosine kinase SRC-induced YAP1-KLF5 module regulates cancer stemness and metastasis in triple-negative breast cancer
Constitutive androstane receptor (CAR) functions as a tumor suppressor via regulating stemness in liver cancer
L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling
TRAF7-targeted HOXA5 acts as a tumor suppressor in prostate cancer progression and stemness via transcriptionally activating SPRY2 and regulating MEK/ERK signaling
Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1
Fascin induces melanoma tumorigenesis and stemness through regulating the Hippo pathway
SRC
SRC
SRC
RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axis
P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs
FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness